Substance Abuse

DIAGNOSTIC CRITERIA

  • Substance is often taken in larger amounts and/or over a longer period than the patient intended.

  • Persistent attempts or one or more unsuccessful efforts made to cut down or control substance use.

  • A great deal of time is spent in activities necessary to obtain the substance, use the substance, or recover from effects.

  • Craving or strong desire or urge to use the substance

  • Recurrent substance use resulting in a failure to fulfill major role obligations at work, school, or home.

  • Continued substance use despite having persistent or recurrent social or interpersonal problem caused or exacerbated by the effects of the substance.

  • Important social, occupational or recreational activities given up or reduced because of substance use.

  • Recurrent substance use in situations in which it is physically hazardous.

  • Substance use is continued despite knowledge of having a persistent or recurrent physical or psychological problem that is likely to have been caused or exacerbated by the substance.

  • Tolerance, as defined by either of the following:

    a. Markedly increased amounts of the substance in order to achieve intoxication or desired effect

    b. Markedly diminished effect with continued use of the same amount

  • Withdrawal, as manifested by either of the following:

    a. The characteristic withdrawal syndrome for the substance

  • The same (or a closely related) substance is taken to relieve or avoid withdrawal symptoms

 
  • Diagnostic and Statistical Manual of Mental Disorders, Fifth Edition

    Alcohol Use Disorder (ICD 10)

    305.00 (F10.10) Mild 2-3 symptoms present
    303.90(F10.20) Moderate 4-5 symptoms present
    303.90(F10.20) Severe 6+ symptoms present

    Phencyclidine Use Disorder

    305.90 (F16.10) Mild 2-3 symptoms present
    304.60 (F16.20) Moderate 4-5 symptoms present
    304.60 (F16.20) Severe 6+ symptoms present

    Inhalant Use Disorder:

    305.90 (F18.10) Mild 2-3 symptoms present
    304.60 (F18.20) Moderate 4-5 symptoms present
    304.60 (F18.20) Severe 6+ symptoms present

    Stimulant Use Disorder

    Mild: Presence of 2-3 symptoms

    305.70 (F15.10) Amphetamine-type substance
    305.60 (F14.10) Cocaine
    305.70 (F15.10) Other or unspecified stimulant

    Moderate: Presence of 4-5 symptoms

    304.40 (F15.20) Amphetamine-type substance
    304.20 (F14.20) Cocaine
    304.40 (F15.10) Other or unspecified stimulant

    Severe: Presence of 6 or more symptoms

    304.40 (F15.20) Amphetamine-type substance
    304.20 (F14.20) Cocaine
    304.40 (F15.10) Other or unspecified stimulant

    Cannabis Use Disorder

    305.20 (F12.10) Mild 2-3 symptoms present
    304.30 (F12.20) Moderate 4-5 symptoms present
    304.30 (F12.20) Severe 6+ symptoms present

    Other Hallucinogen Use Disorder

    305.30 Mild Presence of 2-3 symptoms
    304.50 Moderate Presence of 4-5 symptoms
    304.50 Severe Presence of 6 or more

    Opioid Use Disorder

    305.50 (F11.10) Mild 2-3 symptoms present
    304.00 (F11.20) Moderate 4-5 symptoms present
    304.00 (F11.20) Severe 6+ symptoms present

    Sedative, Hypnotic, or Anxiolytic Use Disorder

    305.40 (F13.10) Mild 2-3 symptoms present
    304.10 (F13.20) Moderate 4-5 symptoms present
    304.10 (F13.20) Severe 6+ symptoms present

    Tobacco Use Disorder

    305.10 (Z72.0) Mild 2-3 symptoms present
    304.10 (F17.20) Moderate 4-5 symptoms present
    304.10 (F17.20) Severe 6+ symptoms present

Previous
Previous

Cognitive Dissonance

Next
Next

Colors